We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
-3.26%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.67B
AUM Growth
+$134M
Cap. Flow
+$180M
Cap. Flow %
10.83%
Top 10 Hldgs %
42.41%
Holding
98
New
25
Increased
27
Reduced
17
Closed
21

Top Buys

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$39.2M
2
UTHR icon
United Therapeutics
UTHR
+$36.1M
3
CAR icon
Avis
CAR
+$33.4M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$33.3M
5
RL icon
Ralph Lauren
RL
+$29M

Top Sells

Rank Stock Value
1
SGI
Somnigroup International
SGI
+$40.4M
2
PRKS icon
United Parks & Resorts
PRKS
+$34.4M
3
INCY icon
Incyte
INCY
+$29.4M
4
CVS icon
CVS Health
CVS
+$28.6M
5
VNDA icon
Vanda Pharmaceuticals
VNDA
+$27M

Sector Composition

Rank Sector Weight
1 Healthcare 37.02%
2 Consumer Discretionary 19.39%
3 Consumer Staples 7.59%
4 Industrials 2.26%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$774B
$198M 11.87%
680,000
-40,000
-6% -$11.4M
AVTX icon
2
Avalo Therapeutics
AVTX
$1.02B
$81.7M 4.91%
6,077
+378
+7% +$4.95M
CPB icon
3
CALL
Campbell Soup
CPB
$6.58B
$73.3M 4.4%
2,000,000
+980,000
+96% +$39.9M
CAKE icon
4
CALL
Cheesecake Factory
CAKE
$4.26B
$58.9M 3.54%
1,100,000
+580,000
+112% +$31.4M
HAIN icon
5
CALL
Hain Celestial
HAIN
$50.6M
$54.2M 3.26%
2,000,000
+1,200,000
+150% +$34.2M
SJM icon
6
J.M. Smucker
SJM
$12B
$52.9M 3.18%
516,000
+192,000
+59% +$21M
INCY icon
7
CALL
Incyte
INCY
$23.4B
$48.4M 2.9%
+700,000
New +$48M
CLVS
8
DELISTED
Clovis Oncology, Inc.
CLVS
$48M 2.88%
1,636,000
+1,012,000
+162% +$39.2M
EPC icon
9
Edgewell Personal Care
EPC
$1.37B
$46.2M 2.78%
1,000,000
-92,000
-8% -$4.87M
MNK
10
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$45.1M 2.71%
1,540,000
-860,000
-36% -$24.2M
AMAG
11
DELISTED
AMAG Pharmaceuticals
AMAG
$41.6M 2.5%
2,080,000
– –
ENTA icon
12
Enanta Pharmaceuticals
ENTA
$400M
$39M 2.34%
456,000
+332,000
+268% +$33.3M
PGNX
13
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$38.6M 2.32%
6,158,000
+3,622,000
+143% +$27.8M
UTHR icon
14
United Therapeutics
UTHR
$22.7B
$37.3M 2.24%
+292,000
New +$36.1M
HOG icon
15
Harley-Davidson
HOG
$2.8B
$37.3M 2.24%
824,000
-176,000
-18% -$7.64M
HBI
16
DELISTED
Hanesbrands
HBI
$36.9M 2.21%
2,000,000
+720,000
+56% +$14M
CPRI icon
17
Capri Holdings
CPRI
$1.88B
$36.7M 2.21%
536,000
+118,000
+28% +$8.26M
VYGR icon
18
Voyager Therapeutics
VYGR
$192M
$32.6M 1.96%
1,724,000
+1,292,000
+299% +$24.8M
PLYA
19
DELISTED
Playa Hotels & Resorts
PLYA
$32.3M 1.94%
3,352,000
+416,000
+14% +$4.26M
CAR icon
20
Avis
CAR
$5.67B
$32.1M 1.93%
+1,000,000
New +$33.4M
DFRG
21
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$31.2M 1.87%
3,756,000
+2,756,000
+276% +$27.4M
ATRS
22
DELISTED
Antares Pharma, Inc.
ATRS
$30.6M 1.84%
9,120,000
-2,930,000
-24% -$9.05M
REGN icon
23
Regeneron Pharmaceuticals
REGN
$70.9B
$30.3M 1.82%
75,000
-53,000
-41% -$20.2M
RL icon
24
Ralph Lauren
RL
$22.6B
$30M 1.8%
+218,000
New +$29M
HAIN icon
25
Hain Celestial
HAIN
$50.6M
$27.1M 1.63%
+1,000,000
New +$28.5M
1
2 3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DWM
Diversify Wealth Management Sandy, Utah $5.61B AUM 19.63% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
AIM
Alphinity Investment Management Sydney, Australia $5.68B AUM 26.72% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return

Armistice Capital's Q3 2018 Portfolio in Review

As of Q3 2018, Armistice Capital held 98 positions worth $1.67B, up 8.8% from $1.53B the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Armistice Capital deployed $180M of net new capital in Q3 2018, opening 25 new positions and adding to 27 existing holdings. Its largest new stake was United Therapeutics: 292,000 shares worth $37.3M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Somnigroup International, an estimated $40.4M trimmed.

  • Armistice Capital's largest Q3 2018 buy was United Therapeutics: 292,000 shares worth $37.3M.
  • Armistice Capital added most to Clovis Oncology, Inc. in Q3 2018, an estimated $39.2M increase.
  • Armistice Capital's biggest Q3 2018 reduction was Somnigroup International, cutting an estimated $40.4M.
  • Armistice Capital fully exited United Parks & Resorts in Q3 2018, selling an estimated $34.4M.
  • Armistice Capital's ten largest holdings make up 42% of its $1.67B portfolio in Q3 2018.
  • Armistice Capital opened 25 new positions and closed 21 in Q3 2018.
  • Armistice Capital's portfolio value rose 8.8% quarter-over-quarter to $1.67B.

Based on Armistice Capital's 13F filing for Q3 2018, filed 14 Nov 2018.